We are experts in myeloma…
it’s all we do

 

Our singular focus on myeloma ensures that we bring unparalleled expertise and dedication to everything we do

 

From actionable insights to strategic engagement with leading KOLs and community clinicians, our full suite of  services empowers you to lead in the myeloma market

InSights

MYinSIGHTS provides real-time insights to data being presented at conferences or from the latest publications. Gain an understanding of how the experts view the data.

MYConference Targeted Reports. Collecting insights at medical conferences shouldn’t be hard. MYELOMA360 makes it easy

Engagements

MYBOARD is a new format for Advisory Boards.

In place of single company events, MYBoard is an independent full day advisory board fully managed by MYELOMA360, with four 2-hour time slots for multiple companies, allowing for a focused, efficient, dedicated session to generate insights around your strategic objectives.

Strategy & Consulting

We are a team of seasoned biopharmaceutical specialists dedicated to helping companies strategize and plan their marketing, clinical development and medical affairs activities.

Our expertise is focused in myeloma across the full development lifecycle, allowing us to provide tailored solutions to drive your company’s success.

Everything you need to navigate the myeloma market

Latest insights

Myeloma News

Breaking Financial Barriers: Pharmacists as Value-Driven Health Care Providers

Source: Pharmacy Times articles Pharmacists navigate reimbursement challenges while advocating for legislative support and innovative models to enhance patient care and financial sustainability. Read More

ASCO 2025: Camizestrant With CDK4/6 Inhibitor Improves PFS in Patients With HR+/HER2- Advanced Breast Cancer

Source: Pharmacy Times articles Compared with standard of care, camizestrant in combination with a CDK4/6 inhibitor shows promise in enhancing progression-free survival (PFS) for patients with advanced breast cancer. Read More

To Combat Medication Errors, Proper Pharmacy Inventory Counts Are Essential

Source: Pharmacy Times articles New products are poised to aid pharmacists in proper counting of inventory to prevent medication errors. Read More

Targeted Screening Tools Can Increase Pneumococcal Vaccine Uptake in Health-System Retail Pharmacies

Source: Pharmacy Times articles Implementation of the Plan-Do-Study-Act cycle in health system retail pharmacies significantly increased uptake of 20-valent pneumococcal conjugate vaccine among eligible adults. Read More

Study Finds Vitamin D3 Supplementation Reduces Telomere Attrition

Source: Pharmacy Times articles New research highlights vitamin D's potential to slow telomere shortening, suggesting it may combat aging and promote cellular health. Read More

Vadadustat and Darbepoetin Alfa Show Similar Safety, Efficacy in Patients With NDD-CKD and DD-CKD

Source: Pharmacy Times articles Vadadustat and darbepoetin alfa show similar safety and efficacy in treating CKD-related anemia, with regional differences impacting cardiovascular risks. Read More
Latest Data

Latest Publications

Hepatitis B and C virus infection and risk of multiple myeloma: a systematic review and meta-analysis

BMC Cancer. 2025 Jun 4;25(1):998. doi: 10.1186/s12885-025-14420-5. ABSTRACT BACKGROUND: Multiple...

Observation or treatment for smoldering multiple myeloma? A systematic review and meta-analysis of randomized controlled studies

Blood Cancer J. 2025 May 26;15(1):104. doi: 10.1038/s41408-025-01312-x. ABSTRACT While observation...

Email

info@myeloma360.com